Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Innate Pharma, Bristol-Myers deal

Innate received a $15 million milestone payment from Bristol-Myers under

Read the full 100 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE